欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/2134/001
药品名称Teicoplanina Accordpharma
活性成分
    • teicoplanin 200.0 mg/3 ml
剂型Powder and solvent for solution for infusion
上市许可持有人Astron Research Limited
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • Croatia (HR)
    • Czechia (CZ)
      Teicoplanin 200 mg/3 ml Powder and solvent for solution for injection/infusion or oral solution
    • Germany (DE)
      Teicoplanin 200mg / 3ml Pulver und Lösungsmittel zur Herstellung einer Injektions- bzw. Infusionslösung und einer Lösung zum Einnehmen
    • France (FR)
    • Finland (FI)
    • Ireland (IE)
    • Italy (IT)
    • Malta (MT)
      Teicoplanin 200 mg/3 ml Powder and solvent for solution for injection/infusion or oral solution
    • Netherlands (NL)
    • Sweden (SE)
    • Poland (PL)
      Teicoplanin Accord
    • United Kingdom (GB)
许可日期2020/01/08
最近更新日期2020/02/11
药物ATC编码
    • J01XA02 teicoplanin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase